“CMS Administrator Mehmet Oz, a heart surgeon, persuaded Kennedy to back the coverage expansion by showing him scientific studies about how the medicines can prevent heart disease and diabetes, and data on the resulting cost savings to the federal government, people familiar with the matter said.”
Curta continues to generate impactful data to inform CMS coverage decisions. Congratulations to Curta researcher Tori Dayer for her lead author publication in Value in Health “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare”, selected as Editor’s Choice, and her recent successful dissertation defense. Congratulations Dr. Dayer!
Read the article in the Wall Street Journal
Read the published research paper
Send a note of congratulations: Tori.Dayer@Curta.com
Authors:
Tori Dayer | Iman Nourhussein | Adam Kasle | Ryan Hansen | Angelo N. | Sean Sullivan
The CHOICE Institute | Curta | The University of North Carolina